Deferasirox
- Product NDC
- 43598-852
- 11-digit product format
- 435980852
- Labeler code
- 43598
- Product ID
- 43598-852_95a20658-492c-6693-491b-f651f3a2f25f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Deferasirox
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Dr. Reddy's Laboratories Inc
- Application
- ANDA210945
- Marketing category
- ANDA
- Marketing start
- 2020-06-25
- Substance
- DEFERASIROX
- Active strength
- 180 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| V8G4MOF2V9 | DEFERASIROX | 201530-41-8 | DEFERASIROX |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 43598-852-10 | 43598085210 | 1000 TABLET in 1 BOTTLE (43598-852-10) | 1000 tablet | 2020-06-25 | No | No | Historical |
| 43598-852-30 | 43598085230 | 30 TABLET in 1 BOTTLE (43598-852-30) | 30 tablet | 2020-06-25 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Deferasirox | Dr. Reddy's Laboratories Inc | MSN LABORATORIES PRIVATE LIMITED | 2024-09-30 | HUMAN PRESCRIPTION DRUG LABEL | 5 |